Robert Beckman, M.D., an oncology clinical researcher and mathematical biologist, has played significant leadership roles in developing new oncology clinical research groups at 4 pharmaceutical companies and in 5 cross-company collaborations, and brought 23 new oncology therapies into man, and 2 to market. He has co-invented novel clinical study designs and development strategies for oncology and rare diseases, and leads the Drug Information Association Innovative Design Scientific Working Group, a 250-person international group in this field. Dr. Beckman’s theoretical studies of cancer evolution predicted broad features of tumor evolution before experimental results were available, and have more recently led to a new approach to cancer precision medicine, dynamic precision medicine, which holds promise for significant improvement in patient outcomes. He is currently Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics at Lombardi Comprehensive Cancer Center and the Innovation Center of Biomedical Informatics, Georgetown University Medical Center and Scientific Advisor to the Senior Vice President for Research at Georgetown University. Dr. Beckman’s versatile publication record of over 300 articles, patents, and presentations ranges from computational chemistry to clinical oncology, emphasizing quantitative approaches.